CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects

Journal of Psychopharmacology

Volumn 23, Issue 4, 2009, Pages 460-464

  Maron, E ^a,b   Toru I ^a   MacUrrency Signemets K ^a   Sepp, S ^a   Vasar, V ^a   Shlik, J ^a   Zharkovsky, A ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b North Estonian Regional Hospital   (Estonia)

Author keywords

Anxiety; BDNF; CCK 4; Panic attack; Panic challenge

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; TETRAGASTRIN;

ADULT; ANXIETY; ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PANIC; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROVOCATION TEST; SYMPTOM;

ADOLESCENT; ADULT; ANXIETY; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; MALE; PANIC; PANIC DISORDER; TETRAGASTRIN;

EID: 65649120717     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108089600     Document Type: Article

References (21)

1. Aguilar-Valles A, Sanchez E, de Gortari P, Balderas I, Ramirez-Amaya V, Bermudez-Rattoni F, (2005) Analysis of the stress response in rats trained in the water-maze: differential expression of corticotropin-releasing hormone, CRH-R1, glucocorticoid receptors and brain-derived neurotrophic factor in limbic regions. Neuroendocrinology 82: 306 - 319.
2. Bariohay B, Lebrun B, Moyse E, Jean A, (2005) Brain-derived neurotrophic factor plays a role as an anorexigenic factor in the dorsal vagal complex. Endocrinology 146: 5612 - 5620.
3. Bradwejn J, Koszycki D, Shriqui C, (1991) Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry 48: 603 - 610.
4. Eser D, Schule C, Baghai T, Floesser A, Krebs-Brown A, Enunwa M, (2007) Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study. Psychopharmacology 192: 479 - 487.
5. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, (2005) Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51: 234 - 238.
6. Givalois L, Naert G, Rage F, Ixart G, Arancibia S, Tapia-Arancibia L, (2004) A single brain-derived neurotrophic factor injection modifies hypothalamo-pituitary-adrenocortical axis activity in adult male rats. Mol Cell Neurosci 27: 280 - 295.
7. Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S, (2005) Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 255: 381 - 386.
8. Govindarajan A, Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, (2006) Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proc Natl Acad Sci USA 103: 13208 - 13213.
9. Jerabek I, Boulenger JP, Bradwejn J, Lavallee YJ, Jolicoeur FB, (1999) CCK4-induced panic in healthy subjects I: psychological and cardiovascular effects. Eur Neuropsychopharmacol 9: 149 - 155.
10. Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G, (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57: 1068 - 1072.
11. Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, (2005) Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Prog Neuropsychopharmacol Biol Psychiatry 29: 658 - 663.
12. Koszycki D, Zacharko RM, Le Melledo JM, Bradwejn J, (1998) Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers. Depress Anxiety 8: 1 - 7.
13. Lam P, Cheng CY, Hong CJ, Tsai SJ, (2004) Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder. Neuropsychobiology 49: 178 - 181.
14. Maron E, Toru I, Vasar V, Shlik J, (2004) The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers. J Psychopharmacol 18: 194 - 199.
15. McAllister K, Katz LC, Lo DC, (1999) Neurotrophins and synaptic plasticity. Ann Rev Neurosci 22: 295 - 318.
16. Neumeister A, Yuan P, Young TA, Bonne O, Luckenbaugh DA, Charney DS, (2005) Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry 162: 805 - 807.
17. Pandey SC, Zhang H, Roy A, Misra K, (2006) Central and medial amygdaloid brain-derived neurotrophic factor signaling plays a critical role in alcohol-drinking and anxiety-like behaviors. J Neurosci 26: 8320 - 8331.
18. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.). the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59: 22 - 33.
19. Shimizu E, Hashimoto K, Koizumi H, Kobayashi K, Itoh K, Mitsumori M, (2005) No association of the brain-derived neurotrophic factor (BDNF) gene polymorphisms with panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 29: 708 - 712.
20. Shlik J, Vasar V, Aluoja A, Kingisepp PH, Jagomagi K, Vasar E, (1997) The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers. Biol Psychiatry 42: 206 - 212.
21. Yee BK, Zhu SW, Mohammed AH, Feldon J, (2007) Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice. J Neural Transm 114: 431 - 444.